The Ca2+ channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation
The Ca2+ channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation
复制标题
Ca2 通道抑制剂 2-APB 通过阻断 BAX 和 caspase-3 过度激活来逆转海马中 β-淀粉样蛋白诱导的 LTP 缺陷
DOI:
10.1111/bph.13048
复制
发表时间:
2015-05-01
影响因子:
7.3
通讯作者:
Xiao, Zhi-Cheng
中科院分区:
文献类型:
--
作者:
Hu, Wei-Yan;He, Zhi-Yong;Xiao, Zhi-Cheng
Background and PurposeAt the early stage of Alzheimer's disease (AD), the accumulation of -amyloid (A) oligomers disturbs intracellular Ca2+ homeostasis and disrupts synaptic plasticity of brain neurons. Prevention of A-induced synaptic failure remains an unsolved problem for the treatment of AD. Here, the effects of 2-aminoethoxydiphenyl borate (2-APB), a non-specific, but moderately potent Ca2+ channel inhibitor, on A-induced deficit of synaptic long-term potentiation (LTP) and the underlying molecular mechanisms were explored.Experimental ApproachWe used hippocampal slices and primary cultures of hippocampal neurons from C57BL/6 mice. Methods applied in our study included electrophysiological recording, membrane protein extraction, Western blot assay and Ca2+ imaging.Key Results2-APB at 10M effectively reversed suppression by oligomeric A(1-42) (500nM) of LTP in hippocampal slices. 2-APB also restored phosphorylation and trafficking of the glutamate receptor subunit GluA1 in A-treated hippocampal slices, supporting its protective action on synaptic function. A-mediated abnormal neuronal [Ca2+](i) elevation and hyperactivation of the mitochondrial apoptotic proteins BAX, caspase-3, and glycogen synthase kinase-3, were blocked by 2-APB pretreatment. Moreover, the defict in long term potentiation deficit in hippocampal slices from APP(swe)/PS1(E9) gene mutant mice was rescued by 2-APB at 10M.Conclusions and ImplicationThese data demonstrate that 2-APB is a potentially useful chemical to protect synaptic plasticity against neurotoxic effects of A in AD.